Envisagenics
Stephen Rego is a seasoned professional in the fields of grant development, biochemistry, and molecular biology, currently serving as the Principal Grant Development Specialist at Envisagenics since June 2023. Previous roles include Senior Protocol Development Associate at UNC Lineberger Comprehensive Cancer Center, Industry Trainer at Bionetwork Capstone Center, and Scientific Consultant at Eva Garland Consulting. Rego's postdoctoral experience encompasses work at Wake Forest Baptist Health, focusing on autoimmunity and nucleic acid processing, as well as bio-engineering techniques for gastrointestinal diseases at the Wake Forest Institute of Regenerative Medicine. Rego has also contributed to education as an instructor at Forsyth Technical Community College and UNC Charlotte. An academic background includes a PhD candidate in Molecular, Cellular, and Developmental Biology from the University of North Carolina at Charlotte and a BS in Cell Biology and Anatomy from East Carolina University.
This person is not in any teams
This person is not in any offices
Envisagenics
1 followers
Envisagenics was founded in 2014 as a spinout of Cold Spring Harbor Laboratory. Their mission is to reduce the complexity of biomedical data to accelerate the development of innovative therapeutic solutions through RNA splicing analytics and artificial intelligence.